1. Home
  2. FTK vs EOLS Comparison

FTK vs EOLS Comparison

Compare FTK & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FTK
  • EOLS
  • Stock Information
  • Founded
  • FTK 1985
  • EOLS 2012
  • Country
  • FTK United States
  • EOLS United States
  • Employees
  • FTK N/A
  • EOLS N/A
  • Industry
  • FTK Major Chemicals
  • EOLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • FTK Industrials
  • EOLS Health Care
  • Exchange
  • FTK Nasdaq
  • EOLS Nasdaq
  • Market Cap
  • FTK 473.8M
  • EOLS 417.9M
  • IPO Year
  • FTK N/A
  • EOLS 2018
  • Fundamental
  • Price
  • FTK $15.40
  • EOLS $7.08
  • Analyst Decision
  • FTK Buy
  • EOLS Strong Buy
  • Analyst Count
  • FTK 2
  • EOLS 4
  • Target Price
  • FTK $12.00
  • EOLS $21.25
  • AVG Volume (30 Days)
  • FTK 435.2K
  • EOLS 1.5M
  • Earning Date
  • FTK 11-04-2025
  • EOLS 11-05-2025
  • Dividend Yield
  • FTK N/A
  • EOLS N/A
  • EPS Growth
  • FTK 242.12
  • EOLS N/A
  • EPS
  • FTK 0.93
  • EOLS N/A
  • Revenue
  • FTK $220,501,000.00
  • EOLS $285,823,000.00
  • Revenue This Year
  • FTK $19.47
  • EOLS $13.39
  • Revenue Next Year
  • FTK $11.29
  • EOLS $26.85
  • P/E Ratio
  • FTK $16.66
  • EOLS N/A
  • Revenue Growth
  • FTK 23.56
  • EOLS 15.10
  • 52 Week Low
  • FTK $6.05
  • EOLS $5.71
  • 52 Week High
  • FTK $18.96
  • EOLS $17.12
  • Technical
  • Relative Strength Index (RSI)
  • FTK 47.21
  • EOLS 56.46
  • Support Level
  • FTK $14.52
  • EOLS $6.49
  • Resistance Level
  • FTK $18.10
  • EOLS $7.76
  • Average True Range (ATR)
  • FTK 1.57
  • EOLS 0.45
  • MACD
  • FTK -0.27
  • EOLS 0.03
  • Stochastic Oscillator
  • FTK 19.14
  • EOLS 61.61

About FTK Flotek Industries Inc.

Flotek Industries Inc is a technology-driven specialty chemistry and data company. It has two reportable segments: Its Chemistry Technologies segment includes specialty chemistries, logistics and technology services. It also include integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies, and international supply chain management companies. The Data Analytics segment provides analytical measurement solutions and deliver real-time information and insights to customers to enable optimization of operations and reduction of emissions and their carbon intensity. Key revenue comes from its Chemistry Technologies segment.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: